Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

If you do a deep dive, you might end up with one of these unstoppable stocks in your portfolio today. Reuben Gregg Brewer has ...

Valued at roughly $47.4 billion by market cap, L3Harris Technologies, Inc. (LHX) is reshaping the defense landscape with ...

Valued at a market cap of $36.6 billion, Westinghouse Air Brake Technologies Corporation (WAB) delivers advanced technology ...